Precipio announces first government customer for ICE COLD-PCR™ mutation enrichment tech
Precipio announced it has been approved by the U.S. DoD as a domestic vendor within the Foundation for Advancement of military medicine. Approval will enable DoD funded medical centers to utilize Precipio ICE COLD-PCR technology in mutation testing for active duty as well as military veterans. January 10, 2019